NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company), a global biotechnology platform company committed to ...

Company closed PIPE financing with gross proceeds of up to $175 million, including the possible exercise of warrants, from ...

In the first full quarter since launch, 2,145 healthcare providers prescribed TONMYA, 3,588 patients initiated treatment, and ~5,400 prescriptions were filled Agreement signed in May with leading grou ...

Completed transformative acquisition of PXL-770, (now SCY-770), an innovative, highly selective, direct AMPK activator for the treatment of ...

Announced strategic collaboration with Mayo Clinic, focused on improving care in type 1 diabetes and accelerating development of SC451Continued ...

A new AI framework estimates how cells change over time and infers the gene regulatory networks controlling those changes.

From Genryo’s Sidewinder technology to the Festival of Genomics & Biodata in the UK earlier this year – AI might be trending, ...

New research suggests a simple urine test could help spot conditions including bipolar disorder, ADHD and anorexia much ...

Ranok Therapeutics, a clinical-stage biotechnology company developing innovative therapies, today announced the publication ...

Gain Therapeutics, Inc. (Nasdaq: GANX) ("Gain", or the "Company"), a clinical-stage biotechnology company leading the discovery and development of the ...

Scientists at the University of East Anglia (UK) have contributed to discovering a "control switch" inside our immune cells ...

Researchers Launch BHARAT Study: India’s First Large-Scale Search for Aging Biomarkers India is launching one of its most ...